Drug WatchFirst Generic Epipen ApprovedAschenbrenner, Diane S. MS, RNAuthor Information Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: email@example.com. AJN, American Journal of Nursing: December 2018 - Volume 118 - Issue 12 - p 23-24 doi: 10.1097/01.NAJ.0000549688.51382.a8 Buy Metrics Abstract The Food and Drug Administration has granted Teva Pharmaceuticals approval to market the first generic version of the EpiPen. Some of the controversies surrounding approval of this generic product are described below. Alternatives to the EpiPen are also highlighted. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.